CFTR regulates acute inflammatory responses in macrophages

QJM: An International Journal of Medicine

Volumn 108, Issue 12, 2015, Pages 951-958

  Gao, Z ^a   Su, X ^b,c  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b INSTITUTE PASTEUR OF SHANGHAI   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 THIAZOLIDINONE DERIVATIVE; CFTR INH 172; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOKINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL PERITONITIS; BLOOD VESSEL PERMEABILITY; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; ESCHERICHIA COLI PNEUMONIA; GENE MUTATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LABORATORY; LUNG ALVEOLUS MACROPHAGE; LUNG BLOOD VESSEL; LUNG FLUID; LUNG LAVAGE; MONOCYTE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEUM LAVAGE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE; ACUTE DISEASE; ANIMAL; BACTERIAL PNEUMONIA; BIOSYNTHESIS; CELL MOTION; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MOUSE; DEFICIENCY; DISEASE MODEL; ESCHERICHIA COLI INFECTION; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PERITONITIS; PHYSIOLOGY;

ACUTE DISEASE; ANIMALS; CELL MOVEMENT; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOKINES; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MACROPHAGES, PERITONEAL; MICE, INBRED CFTR; MONOCYTES; MUTATION; NEUTROPHILS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERITONITIS; PNEUMONIA, BACTERIAL;

EID: 84953391759     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcv067     Document Type: Article

References (37)

1. Mayer ML, Blohmke CJ, FalsafiR, Fjell CD, Madera L, Turvey SE, Hancock RE. Rescue of dysfunctional autophagy attenuates hyperinflammatory responses from cystic fibrosis cells. J Immunol 2013; 190:1227-38.
2. Venkatakrishnan A, Stecenko AA, King G, Blackwell TR, Brigham KL, Christman JW, Blackwell TS. Exaggerated activation of nuclear factor-kappab and altered ikappab-beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol Biol 2000; 23:396-403.
3. van Heeckeren AM, Schluchter MD, Xue W, Davis PB. Response to acute lung infection with mucoid pseudomonas aeruginosa in cystic fibrosis mice. Am J Respir Crit Care Med 2006; 173:288-96.
4. Yang Y, Cheng Y, Lian QQ, Yang L, Qi W, Wu DR, et al. Contribution of CFTR to alveolar fluid clearance by lipoxin a4 via pi3k/AKT pathway in LPS-induced acute lung injury. Mediators Inflamm 2013; 2013:862628.
5. Bonfield TL, Hodges CA, Cotton CU, Drumm ML. Absence of the cystic fibrosis transmembrane regulator (CFTR) from myeloid-derived cells slows resolution of inflammation and infection. J Leukoc Biol 2012; 92:1111-22.
6. Sorio C, Buffelli M, Angiari C, Ettorre M, Johansson J, Vezzalini M, et al. Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis. PLoS One 2011; 6:e22212.
7. Su X, Looney MR, Su HE, Lee JW, Song Y, Matthay MA. Role of CFTR expressed by neutrophils in modulating acute lung inflammation and injury in mice. Inflamm Res 2011; 60:619-32.
8. Zhao C, Su EM, Yang X, Gao Z, Li L, Wu H, et al. Important role of platelets in modulating endotoxin-induced lung inflammation in CFTR-deficient mice. PLoS One 2013; 8:e82683.
9. Wu H, Yang J, Su EM, Li L, Zhao C, Yang X, et al. Lipoxin a4 and platelet activating factor are involved in E. coli or LPS-induced lung inflammation in CFTR-deficient mice. PLoS One 2014; 9: e93003.
10. Di A, Brown ME, Deriy LV, Li C, Szeto FL, Chen Y, et al. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 2006; 8:933-44.
11. O'Sullivan BP, Linden MD, Frelinger AL 3rd, Barnard MR, Spencer-Manzon M, Morris JE, et al. Platelet activation in cystic fibrosis. Blood 2005; 105:4635-41.
12. Mattoscio D, Evangelista V, De Cristofaro R, Recchiuti A, PandolfiA, Di Silvestre S, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response. FASEB J 2010; 24:3970-80.
13. Matute-Bello G, Frevert CW, Kajikawa O, Skerrett SJ, Goodman RB, Park DR, et al. Septic shock and acute lung injury in rabbits with peritonitis: failure of the neutrophil response to localized infection. Am J Respir Crit Care Med 2001; 163:234-43.
14. Su X, Looney M, Robriquet L, Fang X, Matthay MA. Direct visual instillation as a method for efficient delivery of fluid into the distal airspaces of anesthetized mice. Exp Lung Res 2004; 30:479-93.
15. Su X, Matthay MA, Malik AB. Requisite role of the cholinergic alpha7 nicotinic acetylcholine receptor pathway in suppressing Gram-negative sepsis-induced acute lung inflammatory injury. J Immunol 2010; 184:401-10.
16. Su X, Lee JW, Matthay ZA, Mednick G, Uchida T, Fang X, et al. Activation of the alpha7 nAChR reduces acid-induced acute lung injury in mice and rats. Am J Respir Cell Mol Biol 2007; 37: 186-92.
17. Su X. Leading neutrophils to the alveoli: who is the guider? Am J Respir Crit Care Med 2012; 186:472-3.
18. - channel function. Am J Physiol Lung Cell Mol Physiol 2001; 281:L71-L78.
19. Tabary O, Boncoeur E, de Martin R, Pepperkok R, Clement A, Schultz C, et al. Calcium-dependent regulation of nf-(kappa)b activation in cystic fibrosis airway epithelial cells. Cell Signal 2006; 18:652-60.
20. Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodeficiency syndrome. Nat Med 2012; 18:509-19.
21. Verhaeghe C, Remouchamps C, Hennuy B, Vanderplasschen A, Chariot A, Tabruyn SP, et al. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. Biochem Pharmacol 2007; 73:1982-94.
22. Bruscia EM, Zhang PX, Ferreira E, Caputo C, Emerson JW, Tuck D, et al. Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/-mice. Am J Respir Cell Mol Biol 2009; 40:295-304.
23. Mogayzel PJ Jr, Naureckas ET, Robinson KA, Brady C, Guill M, Lahiri T, et al. Cystic fibrosis foundation pulmonary clinical practice guidelines C. Cystic fibrosis foundation pulmonary guideline. Pharmacologic approaches to prevention and eradication of initial pseudomonas aeruginosa infection. Ann Am Thorac Soc 2014; 11:1640-50.
24. Yang X, Zhao C, Gao Z, Su X. A novel regulator of lung inflammation and immunity: pulmonary parasympathetic inflammatory reflex. QJM 2014; 107:789-92.
25. Muir A, Soong G, Sokol S, Reddy B, Gomez MI, Van Heeckeren A, et al. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am J Respir Cell Mol Biol 2004; 30:777-83.
26. Kelly C, Canning P, Buchanan PJ, Williams MT, Brown V, Gruenert DC, et al. Toll-like receptor 4 is not targeted to the lysosome in cystic fibrosis airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2013; 304:L371-82.
27. Berube J, Roussel L, Nattagh L, Rousseau S. Loss of cystic fibrosis transmembrane conductance regulator function enhances activation of p38 and ERK MAPKs, increasing interleukin-6 synthesis in airway epithelial cells exposed to pseudomonas aeruginosa. J Biol Chem 2010; 285: 22299-307.
28. Blohmke CJ, Mayer ML, Tang AC, Hirschfeld AF, Fjell CD, Sze MA, et al. Atypical activation of the unfolded protein response in cystic fibrosis airway cells contributes to p38 mapkmediated innate immune responses. J Immunol 2012; 189: 5467-75.
29. Vij N, Mazur S, Zeitlin PL. CFTR is a negative regulator of nfkappab mediated innate immune response. PLoS One 2009; 4:e4664.
30. Soltys J, Bonfield T, Chmiel J, Berger M. Functional IL-10 deficiency in the lung of cystic fibrosis (CFTR(-/-)) and IL-10 knockout mice causes increased expression and function of b7 costimulatory molecules on alveolar macrophages. J Immunol 2002; 168:1903-10.
31. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, et al. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152:2111-8.
32. Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995; 13:257-61.
33. Legssyer R, Huaux F, Lebacq J, Delos M, Marbaix E, Lebecque P, et al. Azithromycin reduces spontaneous and induced inflammation in deltaf508 cystic fibrosis mice. Respir Res 2006; 7:134.
34. Lavin Y, Winter D, Blecher-Gonen R, David E, Keren-Shaul H, Merad M, et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 2014; 159:1312-26.
35. Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 2014; 159:1327-40.
36. Lee YJ, Han JY, Byun J, Park HJ, Park EM, Chong YH, et al. Inhibiting Mer receptor tyrosine kinase suppresses STAT1, SOCS1/3, and Nf-kB activation and enhances inflammatory responses in lipopolysaccharide-induced acute lung injury. J Leukoc Biol 2012; 91:921-32.
37. Jozefowski S, Czerkies M, Lukasik A, Bielawska A, Bielawski J, Kwiatkowska K, et al. Ceramide and ceramide 1-phosphate are negative regulators of TNF-alpha production induced by lipopolysaccharide. J Immunol 2010; 185:6960-73.